258 related articles for article (PubMed ID: 34014367)
21. Anaplastic lymphoma kinase-directed therapy in inflammatory myofibroblastic tumors.
Tothova Z; Wagner AJ
Curr Opin Oncol; 2012 Jul; 24(4):409-13. PubMed ID: 22664824
[TBL] [Abstract][Full Text] [Related]
22. Fusion of dynactin 1 to anaplastic lymphoma kinase in inflammatory myofibroblastic tumor.
Wang X; Krishnan C; Nguyen EP; Meyer KJ; Oliveira JL; Yang P; Yi ES; Erickson-Johnson MR; Yaszemski MJ; Maran A; Oliveira AM
Hum Pathol; 2012 Nov; 43(11):2047-52. PubMed ID: 22658521
[TBL] [Abstract][Full Text] [Related]
23. Abdominal inflammatory myofibroblastic tumour: Clinicopathological and molecular analysis of 20 cases, highlighting potential therapeutic targets.
Vernemmen AIP; Samarska IV; Speel EM; Riedl RG; Goudkade D; de Bruïne AP; Wouda S; van Marion AM; Verlinden IV; van Lijnschoten I; Friederich P; Winnepenninckx VJL; Zur Hausen A; Sciot RME; van den Hout MFCM
Histopathology; 2024 Apr; 84(5):794-809. PubMed ID: 38155480
[TBL] [Abstract][Full Text] [Related]
24. ALK Immunoexpression is Specific for Inflammatory Myofibroblastic Tumor Among Vulvovaginal Mesenchymal Neoplasms.
Bowman CJ; Medeiros F; Fadare O; Sangoi AR; Horvai AE; Devine WP; McCluggage WG; Rabban JT
Int J Gynecol Pathol; 2023 Jan; 42(1):1-10. PubMed ID: 35180768
[TBL] [Abstract][Full Text] [Related]
25. Primary inflammatory myofibroblastic tumour of the liver: a clinicopathological and genetic study including a subset with ETV6::NTRK3 fusion.
Han Q; Zhang Z; He X; Chen M; Pang X; Chen C; Du T; Zhang H
Histopathology; 2023 May; 82(6):925-936. PubMed ID: 36748182
[TBL] [Abstract][Full Text] [Related]
26. [Clinicopathological features of inflammatory myofibroblastic tumor].
Zhu Y; Ding Y; Song GX; Li X; Ding R; Fan QH; Gong QX
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):194-200. PubMed ID: 33677881
[No Abstract] [Full Text] [Related]
27. A novel fusion of HNRNPA1-ALK in inflammatory myofibroblastic tumor of urinary bladder.
Inamura K; Kobayashi M; Nagano H; Sugiura Y; Ogawa M; Masuda H; Yonese J; Ishikawa Y
Hum Pathol; 2017 Nov; 69():96-100. PubMed ID: 28504207
[TBL] [Abstract][Full Text] [Related]
28. An inflammatory myofibroblastic tumour of the breast with ALK overexpression.
Zhou Y; Zhu J; Zhang Y; Jiang J; Jia M
BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23386486
[TBL] [Abstract][Full Text] [Related]
29. Rare presentation of inflammatory myofibroblastic tumor on a digit.
West CE; Workman A; Moody T; Hosler GA
J Cutan Pathol; 2021 Jul; 48(7):965-968. PubMed ID: 33754372
[TBL] [Abstract][Full Text] [Related]
30. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study.
Cook JR; Dehner LP; Collins MH; Ma Z; Morris SW; Coffin CM; Hill DA
Am J Surg Pathol; 2001 Nov; 25(11):1364-71. PubMed ID: 11684952
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement: a report of two cases and literature review.
Li J; Yin WH; Takeuchi K; Guan H; Huang YH; Chan JK
Diagn Pathol; 2013 Sep; 8():147. PubMed ID: 24034896
[TBL] [Abstract][Full Text] [Related]
32. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.
Lawrence B; Perez-Atayde A; Hibbard MK; Rubin BP; Dal Cin P; Pinkus JL; Pinkus GS; Xiao S; Yi ES; Fletcher CD; Fletcher JA
Am J Pathol; 2000 Aug; 157(2):377-84. PubMed ID: 10934142
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous inflammatory myofibroblastic tumor with CARS-ALK fusion: Case report and literature review.
McCollum KJ; Jour G; Al-Rohil RN
J Cutan Pathol; 2022 Sep; 49(9):795-801. PubMed ID: 35560368
[TBL] [Abstract][Full Text] [Related]
34. A novel LRRFIP1-ALK fusion in inflammatory myofibroblastic tumor of hip and response to crizotinib.
Liu W; Duan Q; Gong L; Yang Y; Huang Z; Guo H; Niu X
Invest New Drugs; 2021 Feb; 39(1):278-282. PubMed ID: 32915420
[TBL] [Abstract][Full Text] [Related]
35. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor.
Bridge JA; Kanamori M; Ma Z; Pickering D; Hill DA; Lydiatt W; Lui MY; Colleoni GW; Antonescu CR; Ladanyi M; Morris SW
Am J Pathol; 2001 Aug; 159(2):411-5. PubMed ID: 11485898
[TBL] [Abstract][Full Text] [Related]
36. ALK-Negative Inflammatory Myofibroblastic Tumor: A Challenging Case in a Premature Newborn.
Regaieg C; Triki M; Cheikrouhou T; Thabet AB; Charfi S; Dhaou MB; Boudawara T; Hamed AB; Hmida N
J Neonatal Perinatal Med; 2023; 16(2):355-359. PubMed ID: 37270815
[TBL] [Abstract][Full Text] [Related]
37. Anaplastic lymphoma kinase inhibitor therapy in the treatment of inflammatory myofibroblastic tumors in pediatric patients: Case reports and literature review.
Craig E; Wiltsie LM; Beaupin LK; Baig A; Kozielski R; Rothstein DH; Li V; Twist CJ; Barth M
J Pediatr Surg; 2021 Dec; 56(12):2364-2371. PubMed ID: 33676744
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory myofibroblastic tumor of the urinary bladder with FN1‑ALK gene fusion: A case report.
Son SM; Woo CG; Lee OJ; Kim YJ; Lee HC
Oncol Lett; 2023 Jun; 25(6):227. PubMed ID: 37153035
[TBL] [Abstract][Full Text] [Related]
39. Intracranial Inflammatory Myofibroblastic Tumor with Negative Expression of Anaplastic Lymphoma Kinase: A Case Report and Review of the Literature.
Wang X; Chen Y; Wu X; Zhang H
World Neurosurg; 2019 May; 125():117-122. PubMed ID: 30735872
[TBL] [Abstract][Full Text] [Related]
40. Vocal cord inflammatory myofibroblastic tumor with mucoid deposits harboring TIMP3-ALK fusion: A potential diagnostic pitfall.
Yorita K; Togashi Y; Nakagawa H; Miyazaki K; Sakata S; Baba S; Takeuchi K; Hayashi Y; Murakami I; Kuroda N; Oda Y; Kohashi K; Yamada Y; Kiyozawa D; Michal M; Michal M
Pathol Int; 2019 Jun; 69(6):366-371. PubMed ID: 31215130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
